Answers are grounded in this paper and cite their sources.
Molecular classification of ECs can be achieved using clinically applicable methods on formalin-fixed paraffin-embedded samples, and provides independent prognostic information beyond established risk factors. This pragmatic molecular classification tool has potential to be used routinely in guiding treatment for individuals with endometrial carcinoma and in stratifying cases in future clinical trials.
No takes yet. Share an insight, caveat, or question.
Talhouk et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: